Hard to Treat Diseases Inc. (HTDS)

Hard to Treat Diseases Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2009
Period Ending	Sep 30, 2010	Dec 31, 2009
Net Income	0.97	0.62
Depreciation & Amortization	0.06	0.03
Operating Cash Flow	1.03	0.66
Capital Expenditures	-0.05	-0.02
Other Investing Activities	-1.37	-1.63
Investing Cash Flow	-1.42	-1.65
Issuance of Common Stock	0.19	0.15
Other Financing Activities	1.06	0.78
Financing Cash Flow	0.25	0.93
Net Cash Flow	-0.14	-0.07
Free Cash Flow	0.98	0.63
Free Cash Flow Margin	15.89%	11.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.